Investment
Features
FeesSafety
Academy
More
Pluang+

Bitcoin options open interest rises to $38.27B, with puts leading near-term trading volume.

Market News
19 Oct 2026
Tokenpost
View Source
Neutral
Bitcoin options open interest rises to $38.27B, with puts leading near-term trading volume.

Bitcoin options open interest increased by 1.07% to $38.27 billion, signaling growing market activity. Medium-term positions favor call options, indicating bullish sentiment, while short-term trading volume is dominated by put options, reflecting caution and demand for downside protection. The highest open-interest contracts are high-strike calls expiring at the end of October, whereas the most traded contracts in the last 24 hours are puts with strikes around $74,000 to $80,000. This mix suggests investors are optimistic about Bitcoin's medium-term price but are hedging against near-term volatility.

Bitcoin options open interest reached $38.27 billion, showing active market interest. For readers following cryptocurrency, here is Pluang's market snapshot as of Oct 19, 2026 18:21 WIB: Among 50 major cryptocurrencies, 23 rose and 25 fell. Enjin Coin (ENJ) dropped 3.05% with 95% sell orders, Filecoin (FIL) fell 2.87% with 61% buy orders, and Cosmos (ATOM) rose 2.78% with 77% buy orders.

More News

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...

Others
Neutral
33 minutes ago
EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint announced that its DURAVYU treatment for wet age-related macular degeneration (wet AMD) did not meet the primary goal of matching the visual improvement of the standard aflibercept treatment in the LUCIA Phase 3 trial. However, DURAVYU demon...

Company Fundamentals
Neutral
33 minutes ago
Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics has been awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials program to support a Phase 1 study of its MT-601 multi-antigen recognizing T cell therapy for locally advanced unresectable pancreatic cancer. Th...

Market News
Bullish
33 minutes ago
Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics announced that Mark Vale, former UPS president and current CEO of Transportation Insight, will join its board and chair the audit committee after its merger with Churchill Capital Corp XI. Vale's extensive experience in global logist...

Company Fundamentals
Bullish
33 minutes ago
JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash, Pakistan's leading digital financial services platform, won the Silver Award in the Banking – InsurTech category at Money20/20 USA 2026 for its health-protection platform Sehat+. This platform provides affordable health insurance to Pakista...

Market News
Bullish
33 minutes ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App